Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference96 articles.
1. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER);Aapro;Ann. Oncol.,2012
2. 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis;Aapro;Drugs,1991
3. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost;Abali;Cancer Investig.,2007
4. Evaluation of the efficacy of aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life with functional living index emesis;Aksu;Balkan Med. J.,2013
5. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006;American Society of Clinical Oncology;J. Clin. Oncol.,2006
Cited by 133 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health-Related Quality of Life And Economic Analysis of Olanzapine Versus Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Malaysia;Value in Health Regional Issues;2024-11
2. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09
3. Effects of technology-based interventions on chemotherapy-induced nausea, vomiting, and quality of life in pediatric patients: A systematic review and meta-analysis;Journal of Pediatric Nursing;2024-09
4. Cannabis for Refractory Chemotherapy-Induced Nausea and Vomiting;Journal of Clinical Oncology;2024-08-20
5. Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study;International Journal of Clinical Oncology;2024-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3